Adil A. Al Hinai

Muscat, MA, Oman

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Journal: Blood advances
Published: September 11, 2025

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Journal: Blood advances
Published: September 11, 2025

2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

Journal: Canadian journal of surgery. Journal canadien de chirurgie
Published: April 28, 2022

Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.

Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.

Journal: Blood
Published: October 18, 2021

Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia.

Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia.

Journal: Cancers
Published: October 05, 2021

Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors.

Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors.

Journal: HemaSphere
Published: February 27, 2021

FLT3-ITD mutations in acute myeloid leukaemia - molecular characteristics, distribution and numerical variation.

FLT3-ITD mutations in acute myeloid leukaemia - molecular characteristics, distribution and numerical variation.

Journal: Molecular oncology
Published: January 15, 2021

PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.

PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.

Journal: Leukemia
Published: June 22, 2020

Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia.

Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia.

Journal: Leukemia
Published: July 24, 2019

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Journal: The New England journal of medicine
Published: March 31, 2018

RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia.

RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia.

Journal: Haematologica
Published: January 02, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026